Clearmind Medicine Announces DSMB Approval To Advance Phase 1/2 Trial Of CMND-100 Into Parts B And C, Marking First Dosing In Alcohol Use Disorder Patients

Loading news article.

Clearmind Medicine Announces DSMB Approval To Advance Phase 1/2 Trial Of CMND-100 Into Parts B And C, Marking First Dosing In Alcohol Use Disorder Patients | WAPE

Clearmind Medicine Announces DSMB Approval To Advance Phase 1/2 Trial Of CMND-100 Into Parts B And C, Marking First Dosing In Alcohol Use Disorder Patients

Article summary

Related companies

Comments —